Sonio got shortlisted for NEXT French Healthcare

Company

Organized by Business France in partnership with Bpifrance, and supported by two competitive clusters, Medicen Paris Région and Lyonbiopôle, the NEXT French Healthcare program selects the best innovative French e-health and MedTech companies wishing to enter the North American market. On May 11, 2021, Sonio will be selected along with 13 other French e-health and MedTech startups.

The NEXT French Healthcare program will enable Sonio to invest in the US market by meeting healthcare industry leaders to gain visibility and forge partnerships with key players, while benefiting from the advice, support and experience of advisors from Business France’s offices in New York, Chicago and Montreal, and North American experts.

Beyond the commercial aspects, the NEXT French Healthcare program also represents an opportunity for Sonio to better refine its strategy with regard to the regulatory aspects and clinical validation linked to its products and services for the US market, including Sonio Diagnostics, Artificial Intelligence software to help diagnose fetal anomalies and associated pathological syndromes, and Sonio Screening, a Saas solution that secures prenatal screening examinations by making them even more comprehensive, structured and personalized according to risk factors.

Mother with her daughter

Ready to see how are we streamlining prenatal ultrasound care?

Contact us and discover Sonio, the next-generation of Prenatal Ultrasounds.